Using the newborn NOD/SCID/IL2rγ null xenotransplantation model, we demonstrate that CD34+CD38+CD19+ cells as well as CD34+CD38−CD19+ cells have the capacities to initiate B-ALL, to infiltrate into ...
CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. Prevention of skin cancer and reduction of keratotic skin lesions during ...
Expanding on the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutchinson Cancer Center’s expertise in providing Human CD34+ HSPCs, we have established a high-efficiency and ...
Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients. The objective of ...
Polycythemia vera is the ultimate phenotypic consequence of the V617F mutation in Janus kinase 2 (encoded by JAK2), but the extent to which this mutation influences the behavior of the involved CD34+ ...
Mulhouse, France, April 23, 2024 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases will share, for the first-time, promising results from EXCELLENT Phase I/IIb ...
Study published in SCIE-indexed international journal Molecular Neurobiology; Three intravenous infusions at four-week intervals showed benefits in cognition, brain metabolism, an ...
Here, we describe the first two patients, one with TDT and the other with SCD, who were infused with CTX001 (autologous CRISPR-Cas9–edited CD34+ HSPCs that were genetically edited to reactivate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results